Paolo Ghia, MD, PhD from the San Raffaele Scientific Institute, Milan, Italy discusses the research activities of the European Research Initiative on CLL (ERIC), which held a General Assembly at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark. Dr Ghia mentions a study that is collecting data on chronic lymphocytic leukemia (CLL) patients treated with bendamustine plus rituximab in second line. He also discusses the creation of a data set of CLL patients in Europe called Minimum Data Set Project, with the aim to map the number of patients in Europe.
Advertisement